Perioperative blood loss in total hip and knee arthroplasty: Outcomes associated with intravenous tranexamic acid use in an academic medical center

SAGE Open Medicine

Volumn 4, Issue , 2016, Pages

  Hogan, Craig A ^a,b   Golightly, Larry K ^a,c   Phong, Suzanne ^a,c   Dayton, Michael R ^a,b   Lyda, Clark ^a,c   Barber, Gerard R ^a,c  

^a UNIVERSITY OF COLORADO HOSPITAL   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

Arthroplasty; Hip; Knee; Tranexamic acid; Transfusion

Indexed keywords

HEMOGLOBIN; TRANEXAMIC ACID;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD TRANSFUSION; CLINICAL OUTCOME; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG COST; FEMALE; HEMATOCRIT; HIP ARTHROPLASTY; HOSPITAL DISCHARGE; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDDLE AGED; OPERATIVE BLOOD LOSS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL KNEE ARTHROPLASTY;

EID: 84995911306     PISSN: None     EISSN: 20503121     Source Type: Journal    
DOI: 10.1177/2050312116637024     Document Type: Article

References (30)

1. Berman AT, Geissele AE and Basacco SJ. Blood loss with total knee arthroplasty. Clin Orthop Relat Res 1988; 234: 137-138.
2. Sehat KR, Evans R and Newman JH. How much blood is really lost in total knee arthroplasty? Correct blood loss management should take hidden loss into account. Knee 2000; 7: 151-155.
3. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology 2010; 113: 182-195.
4. Shander A, Hofmann A, Gombotz H, et al. Estimating the cost of blood: past, present, and future directions. Best Pract Res Clin Anaesthesiol 2007; 21: 271-289.
5. Banerjee S, Issa K, Pivec R, et al. Intraoperative pharmacotherapeutic blood management strategies in total knee arthroplasty. J Knee Surg 2013; 34: 566-585.
6. Mak JCS, Fransen M, Jennings M, et al. Evidence-based review for patients undergoing elective hip and knee replacement. ANZ J Surg 2014; 84: 17-24.
7. Memtsoudis SG, Hargett M, Russell LA, et al. Consensus statement from the consensus conference on bilateral total knee arthroplasty group. Clin Orthop Relat Res 2013; 471: 2649-2657.
8. Shander A, Hofmann A, Ozawa S, et al. Activity-based costs of blood transfusions in surgical patients at four hospitals. Transfusion 2010; 50: 753-765.
9. Hiippala S, Strid L, Wennerstrand M, et al. Tranexamic acid (Cyklokapron) reduces perioperative blood loss associated with total knee arthroplasty. Br J Anaesth 1995; 74: 535-537.
10. Benon G and Fredin H. Fibrinolytic induction with tranexamic acid reduces blood loss and blood transfusion after knee arthroplasty: a prospective, randomized, double-blind study of 86 patients. J Bone Joint Surg Br 1996; 78: 434-440.
11. Hiippala ST, Strid LJ, Wennerstrand MI, et al. Tranexamic acid radically decreases blood loss and transfusions associated with total knee arthroplasty. Anesth Analg 1997; 84: 839-844.
12. Poeran J, Rasul R, Suźuki S, et al. Tranexamic acid use and postoperative outcomes in patients undergoing total hip or knee arthroplasty in the United States: retrospective analysis of effectiveness and safety. BMJ 2014; 349: g4829.
13. Kagoma YK, Crowther MA, Douketis J, et al. Use of antifibrinolytic therapy to reduce transfusion in patients undergoing orthopedic surgery: a systematic review of randomized trials. Thromb Res 2009; 123: 687-696.
14. Yang Z-G, Chen W-P and Wu L-D. Effectiveness and safety of tranexamic acid in reducing blood loss in total knee arthroplasty: a meta-analysis. J Bone Joint Surg Am 2012; 94: 1153-1159.
15. Gandhi R, Evans HMK, Mahomed SR, et al. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184.
16. Zhou X-D, Tao L-J and Wu L-D. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 2013; 133: 1017-1027.
17. Huang F, Wu D, Ma G, et al. The use of tranexamic acid to reduce blood loss and transfusion in major orthopedic surgery: a meta-analysis. J Surg Res 2014; 186: 318-327.
18. Wu Q, Zhang H-A, Liu S-L, et al. Is tranexamic acid clinically effective and safe to prevent blood loss in total knee arthroplasty? A meta-analysis of 34 randomized controlled trials. Eur J Orthop Surg Traumatol 2015; 25: 525-541.
19. Moskal JT, Harris RN and Capps SG. Transfusion cost savings with tranexamic acid in primary total knee arthroplasty from 2009 to 2012. J Arthroplasty 2015; 30: 365-368.
20. Harris RN, Moskal JT and Capps SG. Does tranexamic acid reduce blood transfusion cost for primary total hip arthroplasty? A case-control study. J Arthroplasty 2015; 30: 192-195.
21. McGillivray RG, Tarabichi SB, Hawari MF, et al. Tranexamic acid to reduce blood loss after bilateral total knee arthroplasty: a prospective, randomized double blind study. J Arthroplasty 2011; 26: 24-28.
22. Kelly TC, Tucker KK, Adams MJ, et al. Use of tranexamic acid results in decreased blood loss and decreased transfusions in patients undergoing staged bilateral total knee arthroplasty. Transfusion 2014; 54: 26-30.
23. Smit KM, Naudie DDR, Ralley FE, et al. One dose of tranexamic acid is safe and effective in revision knee arthroplasty. J Arthroplasty 2013; 28(Suppl. 1): 112-115.
24. Maniar RN, Kumar G, Singhi T, et al. Most effective regimen of tranexamic acid in knee arthroplasty: a prospective randomized controlled study in 240 patients. Clin Orthop Relat Res 2012; 470: 2605-2612.
25. Zohar E, Ellis M, Ifrach N, et al. The postoperative blood-sparing efficacy of oral versus intravenous tranexamic acid after total knee replacement. Anesth Analg 2004; 99: 1679-1683.
26. Lin S-Y, Chen C-H, Fu Y-C, et al. The efficacy of combined use of intraarticular and intravenous tranexamic acid on reducing blood loss and transfusion rate in total knee arthroplasty. J Arthroplasty 2015; 30: 776-780.
27. Apfelbaum JL, Nuttall GA, Connis RT, et al. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015; 122: 241-275.
28. Gillette BP, DeSimone LJ, Trousdale RT, et al. Low risk of thromboembolic complications with tranexamic acid after primary total hip and knee arthroplasty. Clin Orthop Relat Res 2013; 471: 150-154.
29. Duncan CM, Gillette BP, Jacob AK, et al. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty. J Arthroplasty 2015; 30: 272-276.
30. Bruce-Brand R, Dragomir R, Baker J, et al. Cerebrovascular infarction following bilateral total knee arthroplasty and tranexamic acid administration. Acta Orthop Belg 2013; 79: 351-354.